The Relationship Between the Tumor Markers and Interstitial Lung Disease

NCT04597814 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 13

Last updated 2020-10-23

No results posted yet for this study

Summary

The serum levels of carcinoembryonic antigen (CEA), carbohydrate antigen 19-9 (CA19-9), CA125 are often increased in interstitial lung disease patients.

This study was undertaken to investigate the source of these serum tumor markers.

Conditions

  • the Relationship Between the Tumor Markers and Interstitial Lung Disease Patients

Interventions

OTHER

No Intervention

No Intervention

Sponsors & Collaborators

  • The First Affiliated Hospital of Guangzhou Medical University

    lead OTHER

Eligibility

Min Age
20 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-01-01
Primary Completion
2020-10-15
Completion
2020-10-15

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04597814 on ClinicalTrials.gov